Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ESR1 | P03372 | 5/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12400927 | 0.99 | KDM4E (0.42) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL12400925 | 0.97 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL124876 | 0.97 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL880864 | 0.94 | HSD17B1 (0.46) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL15449944 | 0.94 | KDM4E (0.48) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL18268578 | 0.94 | L3MBTL1 (0.45) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL13433026 | 0.93 | KDM4E (0.44) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL11910826 | 0.93 | KDM4E (0.42) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL10130146 | 0.93 | L3MBTL1 (0.53) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 | |
| SCHEMBL7603803 | 0.93 | KDM4E (0.41) | KDM4EL3MBTL1ATMHSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359214-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| US-7732065-B2 | Anthracene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-06-08 | — | — | US | disclosed |
| US-7732065-B2 | Anthracene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-06-08 | — | — | US | disclosed |
| US-20080111478-A1 | ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-15 | — | — | US | disclosed |
| US-20080111478-A1 | ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080111478-A1 | ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AR, CYP1A1, ARL1 | KDM4E 2418/4885L3MBTL1 1835/4885ATM 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.